ValuEngine downgraded shares of Envision Healthcare (NYSE:EVHC) from a hold rating to a sell rating in a report released on Monday morning.
A number of other brokerages have also issued reports on EVHC. Jefferies Group set a $46.00 target price on shares of Envision Healthcare and gave the company a buy rating in a research note on Thursday, March 15th. Robert W. Baird set a $45.00 target price on shares of Envision Healthcare and gave the company a buy rating in a research note on Monday, February 26th. Cantor Fitzgerald reissued a hold rating and set a $37.00 target price on shares of Envision Healthcare in a research note on Friday, January 5th. Stephens reissued a hold rating and set a $34.00 target price on shares of Envision Healthcare in a research note on Wednesday, January 10th. Finally, SunTrust Banks set a $40.00 target price on shares of Envision Healthcare and gave the company a buy rating in a research note on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of $42.57.
Envision Healthcare stock traded down $0.93 during midday trading on Monday, reaching $37.97. The stock had a trading volume of 731,861 shares, compared to its average volume of 2,513,123. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $64.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40. The firm has a market capitalization of $4,682.22, a price-to-earnings ratio of 15.69, a P/E/G ratio of 0.97 and a beta of 0.42.
Hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in shares of Envision Healthcare by 6.5% in the 4th quarter. BlackRock Inc. now owns 8,028,329 shares of the company’s stock valued at $277,462,000 after purchasing an additional 487,314 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of Envision Healthcare by 11.2% in the 3rd quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after purchasing an additional 92,339 shares during the last quarter. Ares Management LLC acquired a new stake in shares of Envision Healthcare in the 4th quarter valued at $752,000. OZ Management LP acquired a new stake in shares of Envision Healthcare in the 3rd quarter valued at $131,987,000. Finally, Hexavest Inc. lifted its stake in shares of Envision Healthcare by 1.1% in the 4th quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock valued at $22,655,000 after purchasing an additional 7,270 shares during the last quarter.
COPYRIGHT VIOLATION WARNING: “Envision Healthcare (EVHC) Downgraded by ValuEngine to Sell” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3335672/envision-healthcare-evhc-downgraded-by-valuengine-to-sell.html.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.